National Research Center for Stem Cell Engineering and Technology

Tianjin, China

National Research Center for Stem Cell Engineering and Technology

Tianjin, China
SEARCH FILTERS
Time filter
Source Type

Xu Y.,Peking Union Medical College | Meng H.,National Research Center for Stem Cell Engineering and Technology | Li C.,Peking Union Medical College | Hao M.,Peking Union Medical College | And 9 more authors.
Stem Cells and Development | Year: 2010

Stem cells transplantation holds great promise for the treatment of ischemic diseases through functional revascularization. Umbilical cord-derived mesenchymal stem cells (UC-MSCs) are also an ideal candidate for cell-based bioengineering. Herein, we report on the development of a simple and effective protocol to isolate UC-MSCs, and confirm their endothelial potential both in vitro and in vivo. UC-MSCs were isolated by a novel explantation technique and induced to differentiate into endothelial-like cells. Then UC-MSCs were transplanted into ischemic mouse model and cultured on 3D gel/MMT-CS composite scaffolds. Morphological and proliferation assessments show that sufficient UC-MSCs can be generated during a relatively short culture period with explantation technique. Increased expression of endothelial-specific markers (KDR and vWF), and functional markers (ac-LDL uptake and UEA-1 binding), indicate that functional endothelial progenitor cells are induced after 9 days of in vitro culture. In an ischemic hindlimb mouse model, the ratio of ischemic/nonischemic limb perfusion 4 weeks after MSCs transplantation reached 0.84 ± 0.09. The capillary density of this group was 2.57-fold greater than that of sham-injected mice (P < 0.05). Immunofluorescence and immunohistological analyses indicate that MSCs may act to salvage the ischemic tissue by incorporating into the local vasculature. In vitro, UC-MSCs were observed to incorporate into 3D gel/MMT-CS composite scaffolds, to secrete extracellular matrix, to remain viable, and to retain their proliferation capacity. In conclusion, UC-MSCs isolated by novel yet simple explantation technique are well suited for application in the development of novel stem cell-based revascularization therapies. © 2010, Mary Ann Liebert, Inc.


Wang L.-F.,Zhejiang Medical College | Han Z.-B.,Peking Union Medical College | Li M.,CAS Institute of Biophysics | Yang P.,Peking Union Medical College | And 4 more authors.
Molecular Medicine Reports | Year: 2013

Hemangiopoietin (HAPO) is a novel growth factor stimulating the proliferation of hematopoietic and endothelial progenitor cells in vitro and in vivo. The native protein is a 294-amino acid multimodular protein. The N-terminus constitutes of two somatomedin B (SMB) homology domains that contain 14 cysteines. The central region is a putative heparin-binding domain (pHBD) and the C-terminus contains mucin-like repeats. In the present study, we demonstrated that prokaryotic recombinant human HAPO (rhHAPO) self-associates into a multimeric form with a mass weight of ∼129 kDa, suggesting a homologous tetramer. rhHAPO in its multimeric form was found to be more stable and more potent in promoting HESS-5 cell adhesion. Multimeric rhHAPO had a higher affinity to heparin compared with its dimeric form, although there was no significant conformational change. C-terminal repeats-truncated rhHAPO (rhHAPOΔmucin) was also found to be assembled into a multimer, while deletion of pHBD (rhHAPOΔmucin-pHBD) caused the protein to remain in a dimeric form, demonstrating that SMB domains participate in self-aggregation of the molecule and that the pHBD region promotes the tetramerization.

Loading National Research Center for Stem Cell Engineering and Technology collaborators
Loading National Research Center for Stem Cell Engineering and Technology collaborators